Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H23N7S |
Molecular Weight | 321.444 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CC1=CNC=N1)NC(=N)NCCSCC2=C(C)NC=N2
InChI
InChIKey=JXJRIXGXPTZOCF-SNVBAGLBSA-N
InChI=1S/C14H23N7S/c1-10(5-12-6-16-8-19-12)21-14(15)17-3-4-22-7-13-11(2)18-9-20-13/h6,8-10H,3-5,7H2,1-2H3,(H,16,19)(H,18,20)(H3,15,17,21)/t10-/m1/s1
Sopromidine is a neuroprotective drug. Sopromidine is a potent and stereoselective isomer of the achiral H2-agonist impromidine. The chiral impromidine isomer sopromidine is of special interest as the (R)-configurated compound behaves as gpH2R agonist, whereas the (S)-configurated counterpart is devoid of agonist activity. Both Sopromidine and its S enantiomer acted as antagonists of histamine at H3-autoreceptors with similar potencies (Ki = 5.6 X 10(-8) M and 4.5 X 10(-8) M), whereas Sopromidine acted as an H2-receptor agonist and the S-enantiomer as an H2-receptor antagonist.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2417862
Sopromidine and its S enantiomer acted as antagonists of histamine at H3-autoreceptors with similar potencies (Ki = 5.6 X 10(-8) M and 4.5 X 10(-8) M)
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10593MIG
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL275803
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
XVO1973XSP
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
DTXSID00229613
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
79313-75-0
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
210319
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
100000083770
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
5162
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY | |||
|
C84253
Created by
admin on Fri Dec 15 15:35:26 GMT 2023 , Edited by admin on Fri Dec 15 15:35:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY